
Sign up to save your podcasts
Or


Prof Peter Schmid from Barts Cancer Institute in London reviews available efficacy and safety data guiding the optimal management of metastatic triple-negative breast cancer.
CME information and select publications here.
By Dr. Neil Love4.4
6262 ratings
Prof Peter Schmid from Barts Cancer Institute in London reviews available efficacy and safety data guiding the optimal management of metastatic triple-negative breast cancer.
CME information and select publications here.

135 Listeners

321 Listeners

495 Listeners

31 Listeners

76 Listeners

14 Listeners

17 Listeners

12 Listeners

0 Listeners

115 Listeners

57 Listeners

290 Listeners

3,333 Listeners

197 Listeners

513 Listeners

57 Listeners

189 Listeners

0 Listeners